Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUFEST first-episode schizophrenia antipsychotic comparison trial
NL-OMON21342Active, not recruiting
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amisulpride, haloperidol, olanzapine, quetiapine and ziprasidone in schizophrenia, schizoaffective disorder and schizophreniform disorder (5 arms). Primary endpoint: Retention to allocated study drug. Started Dec 2002; status: active, not recruiting.
02
Drugs
amisulpridehaloperidololanzapinequetiapineziprasidone
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NL-OMON21342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21342.